Filtros : "Ferraz, J G" Limpar

Filtros



Refine with date range


  • Source: Alimentary Pharmacology and Therapeutics. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DAVID, F L et al. Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers. Alimentary Pharmacology and Therapeutics, v. 12, n. 4, p. 349-354, 1998Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2036.1998.00298.x. Acesso em: 06 jun. 2024.
    • APA

      David, F. L., Da-Silva, C. M., Mendes, F. D., Ferraz, J. G., Muscará, M. N., Moreno Junior, H., et al. (1998). Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers. Alimentary Pharmacology and Therapeutics, 12( 4), 349-354. doi:10.1046/j.1365-2036.1998.00298.x
    • NLM

      David FL, Da-Silva CM, Mendes FD, Ferraz JG, Muscará MN, Moreno Junior H, De Nucci G, Pedrazzoli Junior J. Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers [Internet]. Alimentary Pharmacology and Therapeutics. 1998 ; 12( 4): 349-354.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2036.1998.00298.x
    • Vancouver

      David FL, Da-Silva CM, Mendes FD, Ferraz JG, Muscará MN, Moreno Junior H, De Nucci G, Pedrazzoli Junior J. Acid suppression by omeprazole does not affect orally administered metronidazole bioavailability and metabolism in healthy male volunteers [Internet]. Alimentary Pharmacology and Therapeutics. 1998 ; 12( 4): 349-354.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1046/j.1365-2036.1998.00298.x
  • Source: Journal of Cardiovascular Pharmacology. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FARO, R et al. Characterization of endothelin receptors in isolated, perfused human spleen. Journal of Cardiovascular Pharmacology, v. 31, p. S551-S553, 1998Tradução . . Acesso em: 06 jun. 2024.
    • APA

      Faro, R., Grassi-Kassise, D. M., Boin, I., Withrington, P. G., Opgenorth, T. J., Ferraz, J. G., et al. (1998). Characterization of endothelin receptors in isolated, perfused human spleen. Journal of Cardiovascular Pharmacology, 31, S551-S553.
    • NLM

      Faro R, Grassi-Kassise DM, Boin I, Withrington PG, Opgenorth TJ, Ferraz JG, Antunes E, De Nucci G. Characterization of endothelin receptors in isolated, perfused human spleen. Journal of Cardiovascular Pharmacology. 1998 ; 31 S551-S553.[citado 2024 jun. 06 ]
    • Vancouver

      Faro R, Grassi-Kassise DM, Boin I, Withrington PG, Opgenorth TJ, Ferraz JG, Antunes E, De Nucci G. Characterization of endothelin receptors in isolated, perfused human spleen. Journal of Cardiovascular Pharmacology. 1998 ; 31 S551-S553.[citado 2024 jun. 06 ]
  • Source: Alimentary Pharmacology and Therapeutics. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARVALHO, A F et al. Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori. Alimentary Pharmacology and Therapeutics, v. 12, n. 6, p. 557-561, 1998Tradução . . Disponível em: https://doi.org/10.1016/s0016-5085(98)80343-0. Acesso em: 06 jun. 2024.
    • APA

      Carvalho, A. F., Fiorelli, L. A., Jorge, V. N., Da-Silva, C. M., De Nucci, G., Ferraz, J. G., & Pedrazzoli, J. (1998). Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori. Alimentary Pharmacology and Therapeutics, 12( 6), 557-561. doi:10.1016/s0016-5085(98)80343-0
    • NLM

      Carvalho AF, Fiorelli LA, Jorge VN, Da-Silva CM, De Nucci G, Ferraz JG, Pedrazzoli J. Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori [Internet]. Alimentary Pharmacology and Therapeutics. 1998 ; 12( 6): 557-561.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/s0016-5085(98)80343-0
    • Vancouver

      Carvalho AF, Fiorelli LA, Jorge VN, Da-Silva CM, De Nucci G, Ferraz JG, Pedrazzoli J. Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori [Internet]. Alimentary Pharmacology and Therapeutics. 1998 ; 12( 6): 557-561.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/s0016-5085(98)80343-0
  • Source: Journal of Cardiovascular Pharmacology. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FARO, F et al. Ethanol reduces the endothelin-B receptor-mediated increase in portal inflow resistance in the isolated, perfused canine liver. Journal of Cardiovascular Pharmacology, v. 31, p. S284-S286, 1998Tradução . . Acesso em: 06 jun. 2024.
    • APA

      Faro, F., Ferraz, J. G., Stella, H. J., Faro, R., Antunes, E., Opgennorth, T. J., et al. (1998). Ethanol reduces the endothelin-B receptor-mediated increase in portal inflow resistance in the isolated, perfused canine liver. Journal of Cardiovascular Pharmacology, 31, S284-S286.
    • NLM

      Faro F, Ferraz JG, Stella HJ, Faro R, Antunes E, Opgennorth TJ, Withrington PG, De Nucci G. Ethanol reduces the endothelin-B receptor-mediated increase in portal inflow resistance in the isolated, perfused canine liver. Journal of Cardiovascular Pharmacology. 1998 ; 31 S284-S286.[citado 2024 jun. 06 ]
    • Vancouver

      Faro F, Ferraz JG, Stella HJ, Faro R, Antunes E, Opgennorth TJ, Withrington PG, De Nucci G. Ethanol reduces the endothelin-B receptor-mediated increase in portal inflow resistance in the isolated, perfused canine liver. Journal of Cardiovascular Pharmacology. 1998 ; 31 S284-S286.[citado 2024 jun. 06 ]
  • Source: British Journal of Clinical Pharmacology. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DA-SILVA, C M et al. Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease. British Journal of Clinical Pharmacology, v. 46, n. 2, p. 176-180, 1998Tradução . . Disponível em: https://doi.org/10.1016/s0016-5085(98)84997-4. Acesso em: 06 jun. 2024.
    • APA

      Da-Silva, C. M., David, F. L., Muscará, M. N., Sousa, S. S., Ferraz, J. G., De Nucci, G., et al. (1998). Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease. British Journal of Clinical Pharmacology, 46( 2), 176-180. doi:10.1016/s0016-5085(98)84997-4
    • NLM

      Da-Silva CM, David FL, Muscará MN, Sousa SS, Ferraz JG, De Nucci G, Polimeno NC, Pedrazzoli Junior J. Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease [Internet]. British Journal of Clinical Pharmacology. 1998 ; 46( 2): 176-180.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/s0016-5085(98)84997-4
    • Vancouver

      Da-Silva CM, David FL, Muscará MN, Sousa SS, Ferraz JG, De Nucci G, Polimeno NC, Pedrazzoli Junior J. Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease [Internet]. British Journal of Clinical Pharmacology. 1998 ; 46( 2): 176-180.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1016/s0016-5085(98)84997-4

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024